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Abstract
Background: Short linear motifs in host organisms proteins can be mimicked by viruses to create protein-protein
interactions that disable or control metabolic pathways. Given that viral linear motif instances of host motif regular
expressions can be found by chance, it is necessary to develop filtering methods of functional linear motifs. We
conduct a systematic comparison of linear motifs filtering methods to develop a computational approach for predictin
g motif-mediated protein-protein interactions between human and the human immunodeficiency virus 1 (HIV-1).
Results: We implemented three filtering methods to obtain linear motif sets: 1) conserved in viral proteins (C), 2)
located in disordered regions (D) and 3) rare or scarce in a set of randomized viral sequences (R). The sets C,D, R are
united and intersected. The resulting sets are compared by the number of protein-protein interactions correctly
inferred with them – with experimental validation. The comparison is done with HIV-1 sequences and interactions
from the National Institute of Allergy and Infectious Diseases (NIAID).
The number of correctly inferred interactions allows to rank the interactions by the sets used to deduce them: D ∪ R
and C. The ordering of the sets is descending on the probability of capturing functional interactions.
With respect to HIV-1, the sets C∪R, D∪R, C∪D∪R infer all known interactions between HIV1 and human proteinsmed
iated by linear motifs. We found that the majority of conserved linear motifs in the virus are located in disordered regions.
Conclusion: We have developed a method for predicting protein-protein interactions mediated by linear motifs
between HIV-1 and human proteins. The method only use protein sequences as inputs. We can extend the software
developed to any other eukaryotic virus and host in order to find and rank candidate interactions. In future works we
will use it to explore possible viral attack mechanisms based on linear motif mimicry.
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Background
Virus-host Protein-protein interactions (VHPPIs) are
essential to understand viral attack mechanisms. VHPPIs
are used by viruses to disrupt or modulate host pathways
in order to achieve goals like the evasion of the com-
plement system [1], modulation of the cytokine system
[2] and abrogation of apoptosis [3]. Some of these PPIs
are based on mimicry: a viral protein mimicking a host
protein might interact with the host protein binding part-
ners. The mimicry is achieved through protein sequence
or structural similarity [4]. We focus our study on predict-
ing a subset of PPIs, the ones mediated by mimicked short
linear motifs (SLiMs). SLiM-mediated PPI predictions,
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conveniently ranked, might help researchers to postulate
hypothesis to elucidate viral attack mechanisms, design
antivirals and vaccines [5–8].
A Short linear motif (SLiM) (also called linear motif,
minimotif, ELM, LM) is a short region of a protein, 3 to 12
residues long, with functions like controlling the assembly
of protein complexes, marking proteolytic cleavage, tag-
ging protein localization and enzyme recruiting [9, 10].
SLiMs are structurally compact and participate in transi-
tory low-affinity interactions [11, 12]. SLiMs in eukaryotic
proteins are curated in the ELM database [13, 14].
SLiMs might evolve rapidly in viral disordered regions
through insertions, deletions and mutations [15]. The
new SLiMs can change the PPI networks creating new
advantageous PPIs that can alter the cell cycle [16], form
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protein complexes and mediate conformational changes
[17]. A recent analysis of the experimentally inferred
human-virus PPIs concludes that human proteins inter-
acting with viruses are enriched in SLiMs and binding
interfaces [18].
Viruses use VHPPIs mediated by host-mimicked SLiMs
to hijack cell regulation [19] and execute their viral cycle
[20]. An example of this strategy is the set of SLiM-
mediated interactions of human papilloma virus (HPV)
protein E6 with members of the 14-3-3 protein family and
proteins containing PDZ domains [21].
Experimental determination of VHPPIs is expensive
since the number of proteins for some host organisms
is large, more than 30.000 in humans. There are many
viral protein sequences available but few corresponding
three-dimensional structures resolved to use structure-
based interaction prediction methods. These are reasons
for developing a general method for predicting mimetic
host-virus PPIs based solely in sequence data. A bioinfor-
matic approach to predict SLiM-mediated VHPPIs might
be an inexpensive alternative to experimentation or can
guide experimental design.
SLiMs are represented computationally as regular
expressions. A SLiM instance is a protein subsequence
that matches the regular expression. For instance, a SLiM
represented by the regular expression R.[RK]R. have
several instances like RVRRE in Ebola virus [22] and
RKRRF in Human respiratory syncytial virus A2 [23].
An algorithm for predicting virus-host PPIs consist in
finding viral instances of SLiMs located in host pro-
teins. The viral instances found need to be filtered by
some criteria that increase the probability of inferring real
interactions.
If a SLiM is conserved in a small viral genome it proba-
bly could be used to interact with a host protein. Evans et
al. find that common SLiMs between HIV-1 and humans
are significantly conserved in HIV-1 proteins [24]. They
propose a criterion to filter SLiMs if they are conserved
above a 70% in the available viral sequences.
Viral genomes have high mutation rates and are not
too thermodynamically stable. This seems to favor protein
structures with a small number of inter-residue interac-
tions and a high number of polar residues that account
for the abundance of disordered protein regions [25].
SLiMs occur more frequently in viral protein disordered
regions [26], in different amounts between viral families
[27]. Viral hubs, proteins that have many interactions with
host proteins, tend to have more disordered regions [28].
With these antecedents Hagai et al. propose a criterion
to filter SLiMs based on location in protein disordered
regions [26].
Hagai et al. also propose another criterion to filter
SLiMs based on rarity in a big set of randomized pro-
teins [29]. A SLiM is judged as rare, or hard to form by
pure chance, if it is counted in less than a percentage
of the sequences in the set of randomized proteins, e.g.
1% of the sequences. Hagai et al. find that rare SLiMs
located in disordered regions have a significant enrich-
ment in functional SLiMs i.e. with experimental evidence
for interaction with host proteins [29].
To our knowledge, there is no comparison of SLiM fil-
teringmethods in the literature. For that reason, we imple-
ment and compare the three criteria introduced above for
SLiM filtering: conservation above a threshold of the avail-
able viral sequences, localization in a protein disordered
region and rarity, or difficulty to form by pure chance.
Each filtering method produces a set of SLiMs – con-
served (C), disordered (D) and rare (R). With sets C,D,R
we form derived union and intersection sets: C∪D, C∪R,
D∪R, C ∪D∪R and C ∩D, C ∩R, D∩R, C ∩R∩D. Each
of these sets allow us to predict interactions between the
viral protein containing the SLiM and the host proteins
that interact with the SLiM.
All the sets generated are compared by filtering
strength. They also are compared by the number of VHP-
PIs derived from the set that have supporting evidence in
a database –i.e. correctly predicted. The comparison by
number of VHPPIs correctly predicted by set allow us to
rank the VHPPIs partially.
To conduct the comparison of the sets we choose the
Human immunodeficiency virus (HIV-1). It is the virus
with more bioinformatic data available, with the NIAID
databases for sequences and alignments [30] and for inter-
actions with human proteins [31]. We also use the HIV-1-





We download alignments for HIV-1 proteins env, gag,
nef, pol, rev, vif, vpr, tat, vpu for the year 2014 and an
alignment of Gag-Pol DNA sequences with years previ-
ous to 2015 from the NIAID HIV-1 sequence database
[30]. Gag-Pol sequences were translated following refer-
ence [33]: of 3648 sequences, 3626 containing the slippery
subsequence TTTTTTA were used to perform a compu-
tational translation considering the frameshift at the given
subsequence.
We filter all protein sequences by HIV-1 subtypes B and
C for their worldwide dominance and computationally
cleave some of the alignments in the following manner:
env into gp120, gp41, pol into pr, rt, rtp51, in and gag into
ma, ca, p2, nc, p1, p6 [31]. After the cleavage we eliminate
the gaps and asterisks in the resulting alignments in order
to reinterpret the files as sets of sequences, Fig. 1, Disorder
panel. The number of sequences per HIV-1 protein is in
Additional file 1: Table S1.
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Fig. 1Methodology. The methods are divided in three parts: 1) Disorder: sequence preprocessing and prediction of disordered regions, 2) Counting:
counting of SLiM patterns and instances, and 3) Comparison: analysis of the overlap between predicted interactions against interactions in NIAID
and LMPID databases
Protein disorder prediction with IUPred
Among several disorder prediction algorithms for pro-
teins [34] we use IUPred [35]. This predictor implements a
physical model based on force fields between residues sta-
tistically calibrated with a set of globular proteins in PDB
[35]. Its performance is comparable to other predictors
[36] and can be installed locally.
IUPred is enhanced with a sliding window addition
proposed by Hagai et al. that allows to define disor-
dered regions [37]. Residues with IUPred computed values
higher that 0.4 are considered disordered. For each residue
an average disorder value is computed considering the
IUPred values for surrounding residues in a window of
size 10. This averaging is justified because the disor-
der tendency of the neighbors of a residue influence its
disorder tendency. Residue windows with average disor-
der value higher than 0.4 are considered as disordered.
As IUPred receives as input a Fasta file with only one
sequence, we split Fasta files with multiple sequences, call
IUPred on every split sequence-file, compute the sliding
window based average values and give as output a list of
disordered regions per protein sequence id. We set the par
ameter long when calling IUPred, see Fig. 1, Disorder panel.
Protein randomization
We randomize the HIV-1 proteins to create a big data set.
For each sequence in a protein file we create 1000 shuffled
versions randomizing the residues located in disordered
regions of the sequence, as computed with IUPred. All
disordered residues in a protein are joined together in
a temporary list, shuffled with the modern Fisher–Yates
algorithm, and put back in the disordered regions, leaving
the ordered residues intact.
SLiM counting
We download all the SLiMs, instances and interactions
from the ELM database [14] and create an in-memory
ELM data structure with each SLiM identifier, its regular
expression, its instances and its interactions with pro-
tein domains. We wrote scripts to compute: the number
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of sequences with a given SLiM, the number of SLiM
instances per protein, the number of SLiMs conserved
above a percentage of sequences (set C) and the number
of SLiMs in disordered regions (set D).
After randomizing as described above, we count the rare
(scarce) SLiMs in these shuffled data set, i.e. the SLiMs that
are found in 1% of the randomized sequences or less (set R).
Based on C, D, R we create the union sets C ∪ D, C ∪ R,
D∪R, C ∪D∪R and intersection sets C ∩D, C ∩R, D∩R,
C ∩ R ∩ D. See Fig. 1, panels Counting and Comparison.
Prediction of protein-protein interactions
We download the NIAID human–HIV-1 PPI database
[31]. As the proteins in the database are identified by
RefSeq records and the SLiM-domain interactions given
by the ELM database are given by UniProt records, we
map RefSeq to UniProt identifiers for human proteins
using UniProt id mappings.We also download the LMPID
database that curates virus-host ELM-mediated interac-
tions [32].
For each SLiM set (C,D,R, . . .) obtained per HIV-1
protein we create VHPPIs based on the ELM database
interactions and interacting domains. For each inter-
action reported in ELM we add the human protein
interacting with the SLiM located in the viral protein.
We also add the proteins that contain the domains
listed as interacting with the SLiM. To map domains to
human proteins we used the domain-protein mapping f
or the human proteome in the PFAM ftp server [38].
Figure 1, Comparison panel.
Comparison of filtering methods
To validate a prediction we use two sets: the NIAID
HIV-1-human interactions and the set of ELM mediated
HIV-1-human interactions, as identified in LMPID [32].
We count the number of correctly predicted interactions,
when an interaction deduced with one of the SLiM sets is
in the NIAID database.
For all the SLiM sets obtained, and all the HIV-1 pro-
teins, we analyze the overlap between the set of predicted
human proteins interacting with HIV-1 and the set human
proteins in NIAID interactions. We compute p-values
for this overlap using the hyper-geometric distribution
from the scipy python library, Table 1. The total num-
ber of human proteins was estimated as 30,057 from
reference [39].
Results and discussion
A general method to identify SLiM-mediated PPIs in
eukaryotes
As SLiMs are computationally represented by regu-
lar expressions there is always a possibility of finding
instances in viral sequences by pure chance. For this
reason, it is important to develop SLiM filtering methods.
Three filtering methods are implemented and system-
atically compared: conservation, location in disordered
regions and rarity. The combination of filters produces a
method to predict virus-host PPIs and rank them. The
comparison of filtering methods performance is con-
ducted with the virus with more abundant data, HIV-1. In
Fig. 1 there is an overview of the methods used.
The developed method only use protein sequences as
input and do not depend on protein 3D structures, for this
reason it can be used with any sequenced eukaryotic virus
to infer candidate VHPPIs. The restriction to eukaryotic
viruses is based on the higher number of SLiMs in eukary-
otes and the use of the ELM database, because the ELM
SLiM classes MOD (post-translational modification) and
TRG (targeting sites) are less used in prokaryotes [29].
Candidate interactions
The lists of predicted human-HIV-1 interactions that are
not in the NIAID database are in the [Additional file 1].
Disordered regions and SLiMs in HIV-1 proteins
The disordered regions for HIV-1 proteins are in the
[Additional file 2: Table S2]. They are depicted in Fig. 2.
Subfigures A to U show the predicted disordered con-
tent in HIV-1 proteins and polyproteins. Each protein
sequence is represented as a yellow line and disordered
regions are depicted as red segments.
We find that predicted disordered regions for HIV-1
proteins are relatively conserved. Perhaps the virus must
keep flexibility in their proteins in order to interact with
several partners.
In Fig. 3, we show the percentage of SLiMs conserved
above a 70% of the input sequences that are also located
inside a disordered region. Most of the conserved SLiMs
in HIV-1 are located in protein disordered regions.
The proteins that deviate the most from this tendency
are vpr, vpu, gp41, in, and pr, with a percentage of con-
served motifs that are located in disordered regions of
53.3, 52.9, 48.5, 32.5 and 0% respectively. The reason for
this discrepancy lies in the few disordered regions pre-
dicted in the five proteins. Indeed, pr, in and gp41 are con-
sidered mostly ordered, while vpr and vpu are considered
moderately disordered [40].
A similar correlation between evolutionary conserva-
tion and location in disordered regions was found for
the SLiMs that bind to SH2, SH3 and Ser/Thr Kinase
domains [41].
We use IUPred as disorder predictor only because its
performance finding the disordered regions of the VIF
protein is outstanding compared to other 18 disorder pre-
dictors [36]. One procedure that could be used to avoid
structured regions entirely is a BLAST query against HIV-
1 proteins in the Protein Data Bank excluding hit regions.
However, it seems that disorder is a viral strategy to buffer
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Table 1 P-values for the overlap between predicted interactions and NIAID PPIs
C D R C ∪ D C ∪ R D ∪ R C ∪ D ∪ R C ∩ D D ∩ R
ca 0.00507796 0.00000002 0.00000000 0.00000002 0.00000000 0.00000000 0.00000000 0.00507796 0.01714953
env 0.00004832 0.00000061 0.00000000 0.00000061 0.00000000 0.00000000 0.00000000 0.00004832 0.00255723
gag-pol 0.00000000 0.00000005 0.00001209 0.00000002 0.00000001 0.00000000 0.00000000 0.00000000 0.45495319
gag 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.06194785
gp41 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000
gp120 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000
in 0.01407766 0.00149210 0.00037910 0.01273233 0.00006794 0.00019741 0.00006794 0.00180869 0.75138323
ma 0.03339655 0.10909512 0.00486733 0.10360963 0.00358860 0.00242853 0.00242853 0.07022484 0.27587317
nc 0.64494534 0.00133985 0.00117412 0.00133985 0.00111249 0.00091772 0.00091772 0.64494534 0.01188417
nef 0.00000001 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000001 0.00000002
p1 0.00000000 0.72014940 0.45345098 0.72014940 0.45345098 0.43570901 0.43570901 0.00000000 0.83020275
p6 0.34157458 0.07552893 0.01970226 0.07552893 0.01653915 0.00998080 0.00998080 0.34157458 0.38820910
pol 0.01830077 0.01095662 0.00697424 0.00720988 0.00164925 0.00091331 0.00080792 0.02737953 0.83859008
pr 0.00000598 0.00000000 0.00009718 0.00000598 0.00000360 0.00009718 0.00000360 0.00000000 0.00000000
rev 0.00000484 0.00000005 0.00000000 0.00000005 0.00000000 0.00000000 0.00000000 0.00000484 0.02941335
rt 0.06943981 0.00454698 0.00258551 0.01358586 0.00033604 0.00034422 0.00020241 0.03287650 0.00000000
rtp51 0.75895972 0.77358631 0.61184897 0.70277019 0.56852841 0.56784368 0.55594980 0.83653902 0.99740709
tat 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.35524421
vif 0.00015410 0.00002619 0.00000000 0.00002381 0.00000000 0.00000000 0.00000000 0.00016868 0.00000000
vpr 0.00000015 0.00000029 0.00000000 0.00000002 0.00000000 0.00000000 0.00000000 0.00000346 0.83217081
vpu 0.00464687 0.00277567 0.00000171 0.00092824 0.00000097 0.00000252 0.00000169 0.02055543 0.03182700
The p-value indicates the probability that the overlap between our sets of predicted PPIs and the PPIs with literature support in the NIAID database takes place under the null
hypothesis, that our sets were formed by random sampling. Red values are not significant at a level of 0.05
mutations and increase interactions with host proteins
[42]. In this perspective, small disordered regions could
be located inside structured protein regions to allow some
interactions with the host, and not excluding the struc-
tured regions opens the possibility of finding these regions.
Analysis of SLiM sets obtained
A ranking of SLiM sets by filtering strength
The SLiM set sizes are in Additional file 3: Table S3 and
the SLiM sets for HIV-1 proteins are in the [Additional
file 3]. In Fig. 4 we plot the the number of SLiM regular
expressions that were found in the HIV-1 proteins identi-
fied by set. The intersection SLiM sets C ∩ R (conserved
and rare) and C ∩D∩R (conserved, rare, located in disor-
dered regions) were discarded for being almost empty for
all proteins.
Considering the sizes of SLiM sets we can rank them
by the filtering strength; from low to high filtering. The
obtained ranking is R,D,C,C ∩ D,D ∩ R. The criterion
that filters the most is location in a disordered region and
rarity. It is followed by location in a disordered region and
conservation.
The sets D ∩ R (SLiMs hard to form by pure chance and
located in protein disordered regions) studied by Hagai
et al. [29], tend to have a smaller size than sets C ∩ D,
of SLiMs conserved and located in protein disordered
regions, Fig. 4. The intersection SLiM sets C ∩ R (con-
served and rare) and C∩D∩R (conserved, rare, located in
disordered regions) are almost empty so they can be dis-
carded as useful filtering criteria –data in Additional file 3:
Table S3.
Protein-protein interactions predicted with the SLiM sets
are enriched in experimentally validated HIV-1-human
protein-protein interactions
We validate against two virus-host PPIs databases: NIAID
[31] and LMPID [32]. The NIAID contains 15074 PPIs at
the moment of writing while LMPID contains 2203 PPIs
between several viruses and hosts, with 6 PPIs between
HIV-1 and human proteins.
The validation of the predicted PPIs with the NIAID
database is not the best way to gauge the proportion of
SLiM-based interactions. This database contains PPIs of
all kinds, not only SLiM-mediated ones. However, it is the
most complete virus-host PPI dataset.
A better validation set, conceptually, is constructed with
pairs deemed to interact through a SLiM with the LMPID
database. Nevertheless, this dataset is too small. We do
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Fig. 2 Disordered regions for HIV-1 proteins. Each subfigure from A to U contains an HIV-1 protein or protein precursor. For all subfigures, each
yellow line represents a protein sequence. The red segments represent disordered regions as deduced with IUPred with the sliding window addition
explained in the “Methods” section
the comparison with both databases, selecting the NIAID
database to compare the sets prediction performance and
check the statistical significance of the results.
Although we are suggesting a partial ranking of SLiM-
based predicted PPIs, another addition would be to rank
totally the interactions with a score representing the
probability that the interaction takes place based on
experimental data [43] or other techniques [44]. For the
moment, a total ranking is difficult to achieve given the
scarcity of data about SLiM-mediated PPIs [32, 45].
Fig. 3 Percentage of conserved SLiMs that are located in disordered
regions in HIV-1. We plot the percentage of conserved SLiMs, present
in 70% or more of the input sequences, that are localized in a
predicted disordered region
In the NIAID database
In Fig. 5 we plot the percentage of correctly predicted int-
eractions, i.e. stored in the NIAID database and predicted
with base on our SLiM sets. In Fig. 6 we plot the num-
ber of interactions predicted against the total number
of interactions in the NIAID database per HIV-1 pro-
tein. The number of correctly predicted interactions is in
Additional file 4: Table S4 and the number of novel inter-
actions found with our method is in Additional file 4:
Table S5.
Fig. 4 Number of SLiMs by set. We plot the number of SLiMs (regular
expressions) that were found in HIV-1 proteins. The intersection SLiM
sets C∩R (conserved and rare) and C∩D∩R (conserved, rare, located in
disordered regions) were discarded for being almost null in all entries
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Fig. 5 Percentage of validated interactions per SLiM set. Each subfigure plots the percentage of validated interactions with a SLiM set. Interactions
were validated with the NIAID HIV-1 Human Interaction Database. The percentage of predicted interactions is represented with amagenta bar. The
HIV-1 proteins are sorted by percentage in each subfigure
We use the hyper-geometric distribution to measure the
statistical significance of the sets of interactions we found.
The p-values for the overlap between the PPIs predicted
with base on each SLiM set and the PPIs in the NIAID
database are in Table 1. The sensitivity and specificity for
the SLiM sets as PPI predictors is in Additional file 4:
Table S7 and Additional file 4: Table S8.
In the LMPID database
Using the literature curated LMPID database [32], we find
that the motif sets C,C∩D,C∩R,C∩D∩R capture half of
the interactions in LMPID, while the sets C∪D,C∪R,D∪
R,C∪D∪R,D∪R allow to infer all of them. All the interac-
tions between HIV-1 and human extracted from LMPID
are in Additional file 4: Table S6.
The small number of human-HIV-1 interactions in this
database (six), leaves open two possibilities: the number is
really small, or the number is larger but few experiments
have been performed to detect them. To estimate the
number of human-HIV-1 SLiM-mediated PPIs more work
is needed, perhaps an approach based on combining
expert opinions [46].
PPIs correctly predicted serveas a rankingof filteringmethods
In Fig. 7 we plot the number of predicted interactions
correctly validated against the NIAID database identified
by the SLiM set used to infer them. We find that the
SLiM sets have an almost general tendency with respect
to the number of PPIs correctly predicted across all HIV-1
proteins. For this reason we propose to rank the PPIs
predicted according to the set used to deduce them.
The ranking of the sets we found by its capacity to infer
real interactions is: D∪R,C ∪R,C ∪D,C ∩D,D∩R. This
ranking allow to present the PPIs predicted to researchers
in a partial order: first the set of interactions deduced
with D ∪ R –SLiMs located in disordered regions or hard
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Fig. 6 Number of predicted interactions per SLiM set. The number of predicted interactions by SLiM set, contrasted with the number of interactions
in the NIAID HIV-1 Human Interaction Database. The number of predicted interactions is represented with a red bar. The green bar represents the
total number of interactions in the NIAID database
to form by pure chance, then the set deduced with C
–conserved SLiMs.
Most used SLiMs in HIV-1 proteins suggest HIV-1 extensive
use of human protein signaling and other processes
We consider the set C∩D of SLiMs conserved and located
in disordered regions for their biological relevance to ana-
lyze their human counter domains. In Table 2 we include
the most used SLiMs from this set, i.e the SLiMs that are
present in 10 or more HIV-1 proteins, are conserved, and
localize in a disordered region. In general, most of these
SLiMs would interfere with host signaling. The most used
counter domains are the Protein kinase domain (PF00069
in Pfam) that interact with 5 of the most used SLiMs
and the Peptidase_S8 Subtilase family (PF00082 in Pfam)
that interacts with 2 of the most used cleavage SLiMs.
However, the list of counter domains in Table 2 suggest
that HIV-1 SLiMs interfere with transcription regula-
tion, autophagy, cell cycle control, apoptosis and cellular
transport.
Conclusion
We develop a method to predict virus-host SLiM-
mediated PPIs and rank them. It is applicable to
any eukaryotic virus and host with available protein
sequences. Using data for the most studied virus, HIV-
1, we find a partial ordering of the PPIs obtained based
on the set used to infer the interactions. This order is
descending in the expected probability of inferring real
interactions. We expect that the method gives interest-
ing candidate interactions with other eukaryotic viruses
and hosts. The call for using high-throughput methods
Becerra et al. BMC Bioinformatics  (2017) 18:163 Page 9 of 11
Fig. 7 Number of validated interactions per set. The number of
interactions as validated with the NIAID HIV-1 Human Interaction
Database. Each set is represented by a dashed linewith a different color
to detect SLiM-mediated PPIs illustrates the benefits of a
bioinformatic method that predicts SLiM-mediated PPIs
and might guide experimental design [45].Although the
number of SLiM-mediated PPIs might be small, there
is evidence that these PPIs are used by several viruses,
in contrast to virus-host domain-domain PPIs, that are
virus-specific [18]. This kind of interactions can help to
analyze common viral strategies for infection.
Indeed, in a previous work we used the method with
the viruses in the NCBI virus variation resource to predict
interactions with the proteins from the human protein
synthesis machinery [47]. We found evidence that viruses
interact with Eukaryotic initiation factors 3 and 4, and the
Poly(A)-binding proteins using SLiMs. Even though the
method developed is not a strong predictor, by using sev-
eral viruses, interesting interactions with host subsystems
can be uncovered. In a future work we want to scale the
Table 2 Most used SLiMs conserved and located in HIV-1 disordered regions
SLiM #HIV-proteins Pfam domain Domain name
LIG_WD40_WDR5_VDV_2 17 IPR017986 WD40-repeat-containing domain
DOC_USP7_1 17 PF00917 MATH domain
CLV_NRD_NRD_1 16 PF00675 Insulinase (Peptidase family M16)
CLV_PCSK_KEX2_1 15 PF00082 Peptidase_S8 Subtilase family
MOD_GSK3_1 15 PF00069 Protein kinase domain
MOD_PIKK_1 15 PF00454 Phosphatidylinositol 3- and 4-kinase
CLV_PCSK_SKI1_1 14 PF00082 Peptidase_S8 Subtilase family
LIG_SH3_3 14 PF00018 SH3 domain
MOD_NEK2_1 13 PF00069 Protein kinase domain
LIG_FHA_2 13 PF00498 FHA domain
MOD_CK1_1 13 PF00069 Protein kinase domain
LIG_FHA_1 12 PF00498 FHA domain
DOC_CYCLIN_1 12 PF00134 Dynein light chain type 1
LIG_LIR_Nem_3 12 PF02991 Autophagy protein Atg8 ubiquitin like
DOC_WW_Pin1_4 12 PF00397 WW domain
MOD_ProDKin_1 12 PF00069 Protein kinase domain
MOD_PKA_2 12 PF00069 Protein kinase domain
MOD_CK2_1 12 PF00069 Protein kinase domain
TRG_ER_diArg_1 12 PF00400 WD domain, G-beta repeat
LIG_SH2_STAT5 11 PF00017 SH2 domain
LIG_LIR_Gen_1 11 PF02991 Autophagy protein Atg8 ubiquitin like
CLV_PCSK_PC1ET2_1 11 PF00082 Peptidase_S8 Subtilase family
MOD_GlcNHglycan 11 PF01048 Phosphorylase superfamily
MOD_N-GLC_1 10 PF02516 Oligosaccharyl transferase STT3 subunit
TRG_ENDOCYTIC_2 10 PF00928 Adaptor complexes medium subunit family
From the SLiMs that are conserved in more than 70% of the HIV-1 protein sequences, and are located in disordered regions too we counted how many HIV-1 proteins
include them. In this table we report the SLiMs more commonly used in HIV-1 proteins, the ones that are included in 10 or more of the HIV-1 proteins. The table includes the
counter domain for every SLiM
Becerra et al. BMC Bioinformatics  (2017) 18:163 Page 10 of 11
approach considering all the human proteome and more
human viruses.
In future work we could also incorporate structural
information in the prediction and analysis of SLiM-
mediated VHPPIs in order to create otter SLiM filtering
methods and compare them with the filters obtained
in this work. One possibility is the study of fuzziness
and SLiM flanking regions [48], another one is the use
of disordered binding region prediction methods, like
ANCHOR [49].
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